President and CEO Rick Pauls outlined the company’s development programs for its lead candidate, DM199, during a presentation ...

Even trace amounts can compromise biological products, causing adverse reactions and regulatory headaches. Endotoxin-free recombinant proteins are the solution. What Are the Potential Risks of ...

Activin-A is increasingly recognized as a potential therapeutic agent for conditions such as brain injury and inflammatory diseases. Studies have shown that it can help reduce damage and inflammation, ...

The pre-Series A funding round was co-led by existing backer WaterBridge Ventures and Japanese VC firm Enrission India Capital Founded in 2019, Loopworm manufactures high-protein animal feeds from ...

A group of international researchers reports the availability of a new “map”’ of every gene, protein, and metabolic pathway required for a cell to efficiently secrete recombinant proteins. The team, ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

The first-hand experience of a biopharmaceutical researcher confirms this: “In our pharmacodynamics studies, we needed to inject recombinant proteins as candidate therapeutic drugs into mouse models.

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...